Devon Schlottach
Family · Sullivan, MONPI 1588206908
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 79 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 15.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $643 and has fallen 80.6% since, to $124 in 2025.
Across 79 payments — averaging $18.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$213
- Lilly USA, LLC$204
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$127
- GSK$96
- Novartis$77
- Novo Nordisk$72
- plus $635 from 23 others
What the payments were for
- Food & beverage$1,424100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 9 | $213 |
| Lilly USA, LLC | 11 | $204 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 9 | $127 |
| GSK | 7 | $96 |
| Novartis | 4 | $77 |
| Novo Nordisk | 4 | $72 |
| Amgen | 4 | $64 |
| Lundbeck LLC | 3 | $53 |
| Otsuka America Pharmaceutical, Inc. | 2 | $40 |
| Sanofi | 1 | $39 |
| Exact Sciences | 2 | $37 |
| Edwards Lifesciences | 2 | $36 |
| Valinor Pharma, LLC | 2 | $30 |
| Johnson & Johnson | 2 | $30 |
| Organon | 2 | $29 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $28 |
| Boston Scientific | 1 | $28 |
| Xeris Pharmaceuticals, Inc. | 1 | $25 |
| Axsome Therapeutics, Inc. | 1 | $23 |
| Ultragenyx Pharmaceutical Inc. | 1 | $22 |
| Bayer | 1 | $21 |
| Ironwood Pharmaceuticals, Inc | 1 | $20 |
| Sobi, Inc | 1 | $20 |
| Shield Therapeutics Inc | 1 | $18 |
| Gilead | 1 | $16 |
| Fresenius Kabi USA, LLC | 1 | $15 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $15 |
| AstraZeneca | 1 | $14 |
| Merck | 1 | $13 |
How this compares
$1,424 in reported general payments places this provider in the 70th percentile of 3,812 family providers in Missouri.
Other family in Sullivan
- Shayla SandersKansas City$306K
- Tamera WolfLees Summit$215K
- Tiffany ArnoldFestus$177K
- Tiffany NelsonSedalia$164K
- Chelsey BeckerSaint Peters$104K
- Carey PattonDes Peres$94K
- Marcy MarkesColumbia$92K
- Laura HedigerSpringfield$71K
- Rebecca SeabaughSaint Louis$68K
- Jennifer GriggColumbia$46K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.